Indication:
Proprietary Name- Istodax
Established Name - Romidepsin for Infusion- histone decacetylase (HAC)
inhibitor
Applicant- Gloucester Pharmaceuticals Inc.
Indication-
Cutaneous T-Cell Lymphoma (CTCL) who have received one prior
systemic therapy
Dosage-
14mg/m2 administered by IV infusion over 4hr on Day 1,8,15,on a 28 day cycle
Approved by FDA on 5-11-2010 (Ref- FDA approved List- 2010)
Dosages/ Overdosage Etc:
Indication-
Cutaneous T-Cell Lymphoma (CTCL) who have received one prior
systemic therapy
Dosage-
14mg/m2 administered by IV infusion over 4hr on Day 1,8,15,on a 28 day cycle